Patient is recovering at home
A ninth Quebecer has suffered from vaccine-induced immune thrombotic thrombocytopenia, a rare blood-clotting syndrome, after receiving their first dose of the AstraZeneca-Oxford vaccine, the province's Health Ministry announced Tuesday.
Approximately one in 50,000 people receiving their first shot may get a blood clot, the ministry says.
